AI Drug Discovery Company Cyclica Featured in Globe and Mail

Cyclica harnesses AI and machine learning, along with a vast library of global human genome discovery, to model potential protein interactions and drastically speed up the drug discovery process.

PETER POWER/THE GLOBE AND MAIL

For full article, click here >